Its diseases, all characterized by specific marker proteins (such as Aβ and phosphorylated tau for AD, a-synuclein for PD, TAR43 for ALS [81]), start with local cell alterations attributed for decades to neuronal defects, expanding with time into wider lesions. This evidence concerns the gene MAPT and Alzheimer disease.